These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 11173637)
1. Allelic Losses from Chromosome 17 in Human Osteosarcomas. Sztán M; Pápai Z; Szendrôi M; Looij M; Oláh E Pathol Oncol Res; 1997; 3(2):115-120. PubMed ID: 11173637 [TBL] [Abstract][Full Text] [Related]
2. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis. Niederacher D; Picard F; van Roeyen C; An HX; Bender HG; Beckmann MW Genes Chromosomes Cancer; 1997 Mar; 18(3):181-92. PubMed ID: 9071571 [TBL] [Abstract][Full Text] [Related]
3. A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1. Godwin AK; Vanderveer L; Schultz DC; Lynch HT; Altomare DA; Buetow KH; Daly M; Getts LA; Masny A; Rosenblum N Am J Hum Genet; 1994 Oct; 55(4):666-77. PubMed ID: 7942844 [TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Gao X; Zacharek A; Salkowski A; Grignon DJ; Sakr W; Porter AT; Honn KV Cancer Res; 1995 Mar; 55(5):1002-5. PubMed ID: 7866981 [TBL] [Abstract][Full Text] [Related]
5. Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. Nagai MA; Yamamoto L; Salaorni S; Pacheco MM; Brentani MM; Barbosa EM; Brentani RR; Mazoyer S; Smith SA; Ponder BA Genes Chromosomes Cancer; 1994 Sep; 11(1):58-62. PubMed ID: 7529047 [TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity at BRCA1, TP53, nm-23 and other loci on chromosome 17q in human breast carcinoma. Saleh EM; Wahab AH; Elhouseini ME; Eisa SS J Egypt Natl Canc Inst; 2004 Mar; 16(1):62-8. PubMed ID: 15717000 [TBL] [Abstract][Full Text] [Related]
7. Sublocalization of smallest common regions of deletion on chromosome 17q12-q23 in sporadic primary breast-tumors. Champeme M; Mazoyer S; Stoppalyonnet D; Bieche I; Ithier G; Sobol H; Nogues C; Lidereau R Oncol Rep; 1995 Sep; 2(5):825-31. PubMed ID: 21597825 [TBL] [Abstract][Full Text] [Related]
8. [Genetic instability on chromosome 17q21 in gastric cancer of Chinese patients]. Lin XQ; Liang Y; Ding SP; Li JC Shi Yan Sheng Wu Xue Bao; 2005 Apr; 38(2):148-56. PubMed ID: 16011248 [TBL] [Abstract][Full Text] [Related]
9. Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2. Johnson SM; Shaw JA; Walker RA Int J Cancer; 2002 Mar; 98(2):205-9. PubMed ID: 11857409 [TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity of the BRCA1 and FHIT genes in patients with sporadic breast cancer from Southern Brazil. Santos SC; Cavalli LR; Cavalli IJ; Lima RS; Haddad BR; Ribeiro EM J Clin Pathol; 2004 Apr; 57(4):374-7. PubMed ID: 15047740 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314 [TBL] [Abstract][Full Text] [Related]
12. Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma. Quezado MM; Moskaluk CA; Bryant B; Mills SE; Merino MJ Hum Pathol; 1999 Feb; 30(2):203-7. PubMed ID: 10029450 [TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line. Futreal PA; Cochran C; Marks JR; Iglehart JD; Zimmerman W; Barrett JC; Wiseman RW Cancer Res; 1994 Apr; 54(7):1791-4. PubMed ID: 7511052 [TBL] [Abstract][Full Text] [Related]
14. Low Frequency Loss of Heterozygosity in the BRCA1 Region in Japanese Sporadic Breast Cancer. Yamashita T; Iwase H; Yamashita i; Iwata H; Ito K; Toyama T; Hara Y; Kobayashi S Breast Cancer; 1996 Dec; 3(3):167-172. PubMed ID: 11091753 [TBL] [Abstract][Full Text] [Related]
15. [Loss of heterozygosity and microsatellite instability in the region including BRCA1 of breast cancer in Chinese]. Cui J; Shen F; Jiang F; Wang Y; Bian J; Shen Z Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Dec; 15(6):348-50. PubMed ID: 9845764 [TBL] [Abstract][Full Text] [Related]
16. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Futreal PA; Söderkvist P; Marks JR; Iglehart JD; Cochran C; Barrett JC; Wiseman RW Cancer Res; 1992 May; 52(9):2624-7. PubMed ID: 1568230 [TBL] [Abstract][Full Text] [Related]
17. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Beckmann MW; Picard F; An HX; van Roeyen CR; Dominik SI; Mosny DS; Schnürch HG; Bender HG; Niederacher D Br J Cancer; 1996 May; 73(10):1220-6. PubMed ID: 8630282 [TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity analysis of chromosomes 9, 10 and 17 in gliomas in families. Watling CJ; van Meyel DJ; Ramsay DA; Macdonald DR; Cairncross JG Can J Neurol Sci; 1995 Feb; 22(1):17-21. PubMed ID: 7750067 [TBL] [Abstract][Full Text] [Related]
19. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications. Gao X; Porter AT; Honn KV Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930 [TBL] [Abstract][Full Text] [Related]
20. Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer. Gao X; Zacharek A; Grignon DJ; Sakr W; Powell IJ; Porter AT; Honn KV Oncogene; 1995 Oct; 11(7):1241-7. PubMed ID: 7478543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]